研究单位：[1]Fourth Affiliated Hospital of Hebei Medical University Shijiazhuang, Hebei, China, 050011[2]Jiangsu HengRui Medicine Co., Ltd.
研究目的：
The purpose of this study is to assess the efficacy and safety of apatinib as maintenance therapy after adjuvant chemotherapy in progressive gastric cancer patients with positive exfoliative cancer cells.
